Common Contracts

COLLABORATION AGREEMENT between GALAPAGOS NV and ABBVIE S.À.R.L. Dated as of September 23, 2013

Collaboration Agreement • May 5th, 2015 • Galapagos Nv • Pharmaceutical preparations • New York

• Contract Type
  Collaboration Agreement
• Filed
  May 5th, 2015
• Company
  Galapagos Nv
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Collaboration Agreement (this “Agreement”) is made and entered into effect as of September 23, 2013 (the “Effective Date”) by and between Galapagos NV, a corporation organized under the laws of Belgium and having a principal place of business at Generaal de Wittelaan L11A3, 2800 Mechelen, Belgium (“Galapagos”), and AbbVie S.à.r.l., a corporation organized under the laws of Luxembourg and having a principal place of business at 26 Boulevard Royal; L-2449 Luxembourg (“AbbVie”). Galapagos and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”

Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 COLLABORATION AGREEMENT between GALAPAGOS NV and ABBVIE S.À.R.L. Dated as of September 23,...

Collaboration Agreement • April 15th, 2015 • Galapagos Nv • Pharmaceutical preparations • New York

• Contract Type
  Collaboration Agreement
• Filed
  April 15th, 2015
• Company
  Galapagos Nv
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Collaboration Agreement (this “Agreement”) is made and entered into effect as of September 23, 2013 (the “Effective Date”) by and between Galapagos NV, a corporation organized under the laws of Belgium and having a principal place of business at Generaal de Wittelaan L11A3, 2800 Mechelen, Belgium (“Galapagos”), and AbbVie S.à.r.l., […***…] (“AbbVie”). Galapagos and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”